Skip to main content

Share story

AI

Airia Enables Enterprise-Grade Security for OpenClaw AI Agent Deployments

Airia Enables Enterprise-Grade Security for OpenClaw AI Agent Deployments Image: Primary
Airia announced enterprise security capabilities for OpenClaw on March 20, 2026. The enterprise AI management platform company, based in Atlanta, introduced the features to address safety concerns with the AI agent technology formerly known as Clawdbot and Moltbot. A well-known healthcare organization deployed OpenClaw through Airia's AI Gateway. The deployment provides secure, monitored access while maintaining HIPAA compliance and data protection standards. Kevin Kiley, CEO of Airia, said OpenClaw represents a breakthrough in AI agent capabilities but carries significant security risks that make it unsuitable for enterprise use without proper guardrails. He added that the AI Gateway makes OpenClaw trusted and safe by providing observability, data loss prevention, and agent constraints. Airia's solution includes data loss prevention for real-time auditing of health information, personally identifiable information, and sensitive data. It also provides complete observability into interactions, costs, and usage patterns, along with agent constraints and a routing engine for protections against failures. The platform enables IT teams to configure OpenClaw for employees while maintaining centralized control, monitoring, and security enforcement. Kiley said organizations should not have to choose between innovation and security, and Airia provides a path to its Omni platform as customers mature their AI strategies. As OpenClaw adoption accelerates, Airia provides governance infrastructure to prevent shadow AI risks and ensure responsible usage at scale.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Airia and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital AI
Capital AI

Enveda raises $311 million to advance AI-assisted drug candidates

Enveda has raised $311 million in Series E financing at a $2 billion valuation as it moves drug candidates found through its AI-assisted search of natural compounds into human testing. Catalio Capital Management led the round, wit...

Capital AI
Capital AI

Lightspeed targets $250 million for AI-focused India fund

Lightspeed is seeking $250 million for a new early-stage India fund focused on AI companies, with commitments for 80% of that target already secured, TechCrunch reported from a letter to investors. The proposed fund is half the si...

Science
Science

Infleqtion claims 30 entangled logical qubits on Sqale system

Infleqtion says it created 30 entangled logical qubits on its Sqale quantum computing system, a company-reported step toward operations across error-protected quantum bits. A logical qubit encodes information across multiple physi...

Capital AI
Capital AI

NUS Enterprise launches patent-matching platform and Munich outpost

NUS Enterprise says it has launched Nova, an AI platform developed with Zima Labs to help its staff find commercial partners for university research. It has also established an outpost in Munich through a partnership with Unterneh...

AI Policy
AI Policy

White House asks AI labs to delay model access for UK testers

The White House has asked OpenAI and Anthropic to keep new AI models from the UK's AI Security Institute until the US government tests them, Politico reported. A British official confirmed the reported request to Bloomberg. Politi...

AI Products
AI Products

Microsoft unveils Copilot app with coding and autonomous agents

Microsoft unveiled a redesigned Copilot app that brings chat, coding and autonomous agents into one interface for work. Its Home tab combines chat and task assistance, while Code is designed to create internal apps in a sandbox ho...